A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases

Treatments for women with recurrent brain metastases from breast cancer are limited. In this phase II study, we administered sagopilone to patients with breast cancer and brain metastases. We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Freedman, Rachel A., Bullitt, Elizabeth, Sun, Lixian, Gelman, Rebecca, Harris, Gordon, Ligibel, Jennifer A., Krop, Ian E., Partridge, Ann H., Eisenberg, Emily, Winer, Eric P., Lin, Nancy U.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773692/
https://ncbi.nlm.nih.gov/pubmed/21697017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2011.03.024
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы